Bibliography for Copy of MD7512 Clinical Presentation & Management of Diabetes: Complications & Cardiovascular Disease BETA

Abdul-Ghani, M., DeFronzo, R. A., Del Prato, S., Chilton, R., Singh, R., & Ryder, R. E. J. (2017). Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care, 40(7), 813–820. https://doi.org/10.2337/dc16-2736

Adamsson Eryd, S., Svensson, A.-M., Franzén, S., Eliasson, B., Nilsson, P. M., & Gudbjörnsdottir, S. (2017). Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up. Diabetic Medicine, 34(3), 411–418. https://doi.org/10.1111/dme.13266

Andersson, D. P., Trolle Lagerros, Y., Grotta, A., Bellocco, R., Lehtihet, M., & Holzmann, M. J. (2017). Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction. Heart. https://doi.org/10.1136/heartjnl-2016-310746

Assessing the relationship between admission glucose levels, subsequent length of hospital stay, readmission and mortality. (n.d.). Prime. https://wwww.unboundmedicine.com/medline/citation/22586788/Assessing_the_relationship_between_admission_glucose_levels_subsequent_length_of_hospital_stay_readmission_and_mortality_

Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7

Azmi, S., Ferdousi, M., Alam, U., Petropoulos, I. N., Ponirakis, G., Marshall, A., Asghar, O., Fadavi, H., Jones, W., Tavakoli, M., Boulton, A. J. M., Jeziorska, M., Soran, H., Efron, N., & Malik, R. A. (2017). Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study. Diabetologia. https://doi.org/10.1007/s00125-017-4245-z

Bangalore, S., Kumar, S., Lobach, I., & Messerli, F. H. (2011). Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials. Circulation, 123(24), 2799–2810. https://doi.org/10.1161/CIRCULATIONAHA.110.016337

Barzilay, J. I., Davis, B. R., Pressel, S. L., Cutler, J. A., Einhorn, P. T., Black, H. R., Cushman, W. C., Ford, C. E., Margolis, K. L., Moloo, J., Oparil, S., Piller, L. B., Simmons, D. L., Sweeney, M. E., Whelton, P. K., Wong, N. D., & Wright, J. T. (2012). Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study. Circulation: Cardiovascular Quality and Outcomes, 5(2), 153–162. https://doi.org/10.1161/CIRCOUTCOMES.111.962522

Bianchi, C., Miccoli, R., & Del Prato, S. (2013a). Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction? Current Diabetes Reports, 13(3), 403–410. https://doi.org/10.1007/s11892-013-0371-2

Bianchi, C., Miccoli, R., & Del Prato, S. (2013b). Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction? Current Diabetes Reports, 13(3), 403–410. https://doi.org/10.1007/s11892-013-0371-2

Black, J. A., Sharp, S. J., Wareham, N. J., Sandbaek, A., Rutten, G. E., Lauritzen, T., Khunti, K., Davies, M. J., Borch-Johnsen, K., Griffin, S. J., & Simmons, R. K. (2014). Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial. British Journal of General Practice, 64(621), e208–e216. https://doi.org/10.3399/bjgp14X677833

Boulton, A. J., Jeffcoate, W. J., Jones, T. L., & Ulbrecht, J. S. (2009). International collaborative research on Charcot’s disease - 2009. The Lancet, 373(9658), 105–106. https://doi.org/10.1016/S0140-6736(09)60019-2

Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., & Cornu, C. (2011). Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ, 343(jul26 1), d4169–d4169. https://doi.org/10.1136/bmj.d4169

Braffett, B. H., Wessells, H., & Sarma, A. V. (2016). Urogenital Autonomic Dysfunction in Diabetes. Current Diabetes Reports, 16(12). https://doi.org/10.1007/s11892-016-0824-5

Çakici, N., Fakkel, T. M., van Neck, J. W., Verhagen, A. P., & Coert, J. H. (2016a). Systematic review of treatments for diabetic peripheral neuropathy. Diabetic Medicine, 33(11), 1466–1476. https://doi.org/10.1111/dme.13083

Çakici, N., Fakkel, T. M., van Neck, J. W., Verhagen, A. P., & Coert, J. H. (2016b). Systematic review of treatments for diabetic peripheral neuropathy. Diabetic Medicine, 33(11), 1466–1476. https://doi.org/10.1111/dme.13083

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0140673614607947

Cefalu, W. T., Rosenstock, J., LeRoith, D., Blonde, L., & Riddle, M. C. (2016). Getting to the "Heart” of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory”. Diabetes Care, 39(5), 664–667. https://doi.org/10.2337/dc16-0405

Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet. https://doi.org/10.1016/S0140-6736(17)30058-2

Cheung, N., Mitchell, P., & Wong, T. Y. (2010). Diabetic retinopathy. The Lancet, 376(9735), 124–136. https://doi.org/10.1016/S0140-6736(09)62124-3

Chloe L. Edridge. (2015). Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS ONE, 10(6). https://doi.org/doi:  10.1371/journal.pone.0126427

Clokie, M., Greenway, A. L., Harding, K., Jones, N. J., Vedhara, K., Game, F., & Dhatariya, K. K. (2017). New horizons in the understanding of the causes and management of diabetic foot disease: report from the 2017 Diabetes UK Annual Professional Conference Symposium. Diabetic Medicine, 34(3), 305–315. https://doi.org/10.1111/dme.13313

Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., O’Brien, E., & Östergren, J. (2005). Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet, 366(9489), 895–906. https://doi.org/10.1016/S0140-6736(05)67185-1

Dana Dabelea. (n.d.). Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA, 317(8), 825–835. https://doi.org/10.1001/jama.2017.0686

Denig, P., Schuling, J., Haaijer-Ruskamp, F., & Voorham, J. (2014). Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ, 349(sep25 6), g5651–g5651. https://doi.org/10.1136/bmj.g5651

Dhatariya, K. K., & Vellanki, P. (2017). Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). Current Diabetes Reports, 17(5). https://doi.org/10.1007/s11892-017-0857-4

Dhatariya, K., Levy, N., Kilvert, A., Watson, B., Cousins, D., Flanagan, D., Hilton, L., Jairam, C., Leyden, K., Lipp, A., Lobo, D., Sinclair-Hammersley, M., & Rayman, G. (2012). NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabetic Medicine, 29(4), 420–433. https://doi.org/10.1111/j.1464-5491.2012.03582.x

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. (2010). The Lancet, 375(9733), 2215–2222. https://doi.org/10.1016/S0140-6736(10)60484-9

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. (2011). New England Journal of Medicine, 364(9), 829–841. https://doi.org/10.1056/NEJMoa1008862

Diabetes Mellitus Type 2: A Driving Force for Urological Complications - ClinicalKey. (n.d.-a). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321

Diabetes Mellitus Type 2: A Driving Force for Urological Complications - ClinicalKey. (n.d.-b). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321

Diabetic foot problems: prevention and management  | Guidance and guidelines | NICE. (n.d.). https://www.nice.org.uk/guidance/ng19

Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., Warren, S. R., Goldman, S., McCarren, M., Vitek, M. E., Henderson, W. G., & Huang, G. D. (2009). Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. New England Journal of Medicine, 360(2), 129–139. https://doi.org/10.1056/NEJMoa0808431

Dwamena, F., Holmes-Rovner, M., Gaulden, C. M., Jorgenson, S., Sadigh, G., Sikorskii, A., Lewin, S., Smith, R. C., Coffey, J., Olomu, A., & Beasley, M. (1996). Interventions for providers to promote a patient-centred approach in clinical consultations. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.CD003267.pub2

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). (1998). The Lancet, 352(9131), 854–865. https://doi.org/10.1016/S0140-6736(98)07037-8

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus. (2010). New England Journal of Medicine, 362(17), 1563–1574. https://doi.org/10.1056/NEJMoa1001282

Effects of Different Blood Pressure–Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus. (2005). Archives of Internal Medicine, 165(12). https://doi.org/10.1001/archinte.165.12.1410

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. (2010a). New England Journal of Medicine, 362(17), 1575–1585. https://doi.org/10.1056/NEJMoa1001286

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. (2010b). New England Journal of Medicine, 362(17), 1575–1585. https://doi.org/10.1056/NEJMoa1001286

Effects of Intensive Glucose Lowering in Type 2 Diabetes. (2008). New England Journal of Medicine, 358(24), 2545–2559. https://doi.org/10.1056/NEJMoa0802743

Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME - ClinicalKey. (n.d.). https://www.clinicalkey.com/#!/content/journal/1-s2.0-S1262363617300022

Ele Ferrannini. (2015). Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. European Heart Journal, 36(34), 2288–2296. http://eurheartj.oxfordjournals.org/content/36/34/2288

Elliott, W. J., & Meyer, P. M. (2007). Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. The Lancet, 369(9557), 201–207. https://doi.org/10.1016/S0140-6736(07)60108-1

Ferrannini, E., & Cushman, W. C. (2012). Diabetes and hypertension: the bad companions. The Lancet, 380(9841), 601–610. https://doi.org/10.1016/S0140-6736(12)60987-8

Filippatos, T., Tsimihodimos, V., Pappa, E., & Elisaf, M. (2017). Pathophysiology of diabetic dyslipidaemia. Current Vascular Pharmacology, 15(999), 1–1.

Fisher, L., Gonzalez, J. S., & Polonsky, W. H. (2014). The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Medicine, 31(7), 764–772. https://doi.org/10.1111/dme.12428

Foresta, C., Ferlin, A., Lenzi, A., & Montorsi, P. (2017). The great opportunity of the andrological patient: cardiovascular and metabolic risk assessment and prevention. Andrology. https://doi.org/10.1111/andr.12342

Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., Inzucchi, S. E., Kosiborod, M., Nelson, R. G., Patel, M. J., Pignone, M., Quinn, L., Schauer, P. R., Selvin, E., & Vafiadis, D. K. (2015). Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care, 38(9), 1777–1803. https://doi.org/10.2337/dci15-0012

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. (2017). New England Journal of Medicine, 376(16), 1507–1516. https://doi.org/10.1056/NEJMoa1612836

Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008). Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. New England Journal of Medicine, 358(6), 580–591. https://doi.org/10.1056/NEJMoa0706245

Gæde, P., Oellgaard, J., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2016). Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia, 59(11), 2298–2307. https://doi.org/10.1007/s00125-016-4065-6

Game, F. (2016). Classification of diabetic foot ulcers. Diabetes/Metabolism Research and Reviews, 32, 186–194. https://doi.org/10.1002/dmrr.2746

Giorgino, F., Home, P. D., & Tuomilehto, J. (2016). Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear? Diabetes Care, 39(Supplement 2), S187–S195. https://doi.org/10.2337/dcS15-3023

Giovanni Corona. (2016). Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors. PLoS ONE, 11(10). https://doi.org/doi:  10.1371/journal.pone.0157915

Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015a). Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 372(23), 2197–2206. https://doi.org/10.1056/NEJMoa1414266

Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015b). Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 372(23), 2197–2206. https://doi.org/10.1056/NEJMoa1414266

Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., Maggioni, A. P., Marso, S. P., Öhman, P., Pagidipati, N. J., Poulter, N., Ramachandran, A., Zinman, B., & Hernandez, A. F. (2017). Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 377(13), 1228–1239. https://doi.org/10.1056/NEJMoa1612917

Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008). 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 359(15), 1577–1589. https://doi.org/10.1056/NEJMoa0806470

Holt, R. I. G. (2010). Textbook of diabetes (4th ed). Wiley-Blackwell. http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077

Holt, R. I. G. (2017). Understanding of the causes and management of diabetic foot disease. Diabetic Medicine, 34(3), 303–304. https://doi.org/10.1111/dme.13319

Holt, R. I. G., Cockram, C., Flyvbjerg, A., & Goldstein, B. J. (2016). Textbook of Diabetes (5th ed). John Wiley & Sons, Incorporated. http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056

Holt, R. I. G., Cockram, C. S., Flyvbjerg, A., & Goldstein, B. J. (Eds.). (2017). Textbook of diabetes (Fifth edition). Wiley Blackwell. http://ezproxy.lib.le.ac.uk/login?url=http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=4769056

Hotaling, J. M., Sarma, A. V., Patel, D. P., Braffett, B. H., Cleary, P. A., Feldman, E., Herman, W. H., Martin, C. L., Jacobson, A. M., Wessells, H., & Pop-Busui, R. (2016a). Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. Diabetes Care, 39(9), 1587–1593. https://doi.org/10.2337/dc16-0059

Hotaling, J. M., Sarma, A. V., Patel, D. P., Braffett, B. H., Cleary, P. A., Feldman, E., Herman, W. H., Martin, C. L., Jacobson, A. M., Wessells, H., & Pop-Busui, R. (2016b). Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. Diabetes Care, 39(9), 1587–1593. https://doi.org/10.2337/dc16-0059

Hypertension: Clinical Management of Primary Hypertension in Adults | NICE guideline 127. August 2011. (n.d.). http://www.nice.org.uk/guidance/cg127

Ian Blumer, MD, FRCPC1, 2, Maureen Clement, MD, CCFP3, ,. (n.d.). Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges. Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges. http://www.sciencedirect.com.ezproxy4.lib.le.ac.uk/science/article/pii/S0149291816307792

Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858717300335

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. (2008). New England Journal of Medicine, 358(24), 2560–2572. https://doi.org/10.1056/NEJMoa0802987

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. (2005). New England Journal of Medicine, 353(25), 2643–2653. https://doi.org/10.1056/NEJMoa052187

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials- ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300998

International Textbook of Diabetes Mellitus (4th ed.). (2015). John Wiley & Sons, Incorporated. http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=1895437

Jhamb, S., Vangaveti, V. N., & Malabu, U. H. (2016). Genetic and molecular basis of diabetic foot ulcers: Clinical review. Journal of Tissue Viability, 25(4), 229–236. https://doi.org/10.1016/j.jtv.2016.06.005

Jin, D., Xu, Y., Geng, D., & Yan, T. (2010). Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice, 89(1), 10–15. https://doi.org/10.1016/j.diabres.2010.03.021

Johal, S., Jackson-Spence, F., Gillott, H., Tahir, S., Mytton, J., Evison, F., Stephenson, B., Nath, J., & Sharif, A. (2017). Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study. Diabetic Medicine. https://doi.org/10.1111/dme.13383

Kaul, S. (2017). Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care, 40(7), 821–831. https://doi.org/10.2337/dc17-0291

Khunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K. (2015a). Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study. Diabetes Care, 38(2), 316–322. https://doi.org/10.2337/dc14-0920

Khunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K. (2015b). Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study. Diabetes Care, 38(2), 316–322. https://doi.org/10.2337/dc14-0920

Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013). Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people. Diabetes Care, 36(11), 3411–3417. https://doi.org/10.2337/dc13-0331

Koye, D. N., Shaw, J. E., Reid, C. M., Atkins, R. C., Reutens, A. T., & Magliano, D. J. (2017). Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabetic Medicine. https://doi.org/10.1111/dme.13324

Kunutsor, S. K., Seidu, S., & Khunti, K. (2017). Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials. Diabetic Medicine, 34(3), 316–327. https://doi.org/10.1111/dme.13133

Liew, G., Mitchell, P., & Wong, T. Y. (2009). Systemic management of diabetic retinopathy. BMJ, 338(feb12 1), b441–b441. https://doi.org/10.1136/bmj.b441

Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., Lederballe-Pedersen, O., Nieminen, M. S., Omvik, P., Oparil, S., Wedel, H., Aurup, P., Edelman, J., & Snapinn, S. (2002). Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, 359(9311), 1004–1010. https://doi.org/10.1016/S0140-6736(02)08090-X

Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716000036

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes. (2011). New England Journal of Medicine, 364(9), 818–828. https://doi.org/10.1056/NEJMoa1006524

Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?- ClinicalKey. (n.d.-a). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354

Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?- ClinicalKey. (n.d.-b). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354

Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?- ClinicalKey. (n.d.-c). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354

Malavige, L. S., Wijesekara, P., Ranasinghe, P., & Levy, J. C. (2015). The association between physical activity and sexual dysfunction in patients with diabetes mellitus of European and South Asian origin: The Oxford Sexual Dysfunction Study. European Journal of Medical Research, 20(1). https://doi.org/10.1186/s40001-015-0186-5

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M., & Buse, J. B. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 375(4), 311–322. https://doi.org/10.1056/NEJMoa1603827

Matheus, A. S. de M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. de B. (2013). Impact of Diabetes on Cardiovascular Disease: An Update. International Journal of Hypertension, 2013, 1–15. https://doi.org/10.1155/2013/653789

Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., Pihoker, C., Saydah, S., & Wagenknecht, L. (2017). Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012. New England Journal of Medicine, 376(15), 1419–1429. https://doi.org/10.1056/NEJMoa1610187

Melanie Davies. (2016). The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. Clinical Pharmacology : Advances and Applications, 8. https://doi.org/doi:  10.2147/CPAA.S82008

Micha, R., Peñalvo, J. L., Cudhea, F., Imamura, F., Rehm, C. D., & Mozaffarian, D. (2017). Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA, 317(9). https://doi.org/10.1001/jama.2017.0947

Microvascular Complications and Foot Care. (2017). Diabetes Care, 40(Supplement 1), S88–S98. https://doi.org/10.2337/dc17-S013

Miller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., Feinglos, M. N., Ismail-Beigi, F., Largay, J. F., O’Connor, P. J., Paul, T., Savage, P. J., Schubart, U. K., Sood, A., & Genuth, S. (2010). The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ, 340(jan08 1), b5444–b5444. https://doi.org/10.1136/bmj.b5444

Minimizing Hypoglycemia in Diabetes: Table 1. (2015). Diabetes Care, 38(8), 1583–1591. https://doi.org/10.2337/dc15-0279

Moreton, R. B. R., Stratton, I. M., Chave, S. J., Lipinski, H., & Scanlon, P. H. (2017). Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabetic Medicine, 34(7), 993–999. https://doi.org/10.1111/dme.13350

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. (2017). New England Journal of Medicine, 377(3), 300–301. https://doi.org/10.1056/NEJMc1706292

Navaneethan, S. D., Schold, J. D., Jolly, S. E., Arrigain, S., Winkelmayer, W. C., & Nally, J. V. (2017). Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2016.11.018

Nicolucci, A., & Standl, E. (2011). Antiplatelet Therapy for Every Diabetic Person? Diabetes Care, 34(Supplement_2), S150–S154. https://doi.org/10.2337/dc11-s210

Older antidiabetic drugs | The British Journal of Cardiology. (n.d.). https://bjcardio.co.uk/2018/03/older-antidiabetic-drugs/

Omland, T., Randby, A., Hrubos-Strøm, H., Røsjø, H., & Einvik, G. (2016). Relation of Erectile Dysfunction to Subclinical Myocardial Injury. The American Journal of Cardiology, 118(12), 1821–1825. https://doi.org/10.1016/j.amjcard.2016.08.070

Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015). Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality. JAMA, 313(1). https://doi.org/10.1001/jama.2014.16107

P Naidoo. (2015). Lower limb complications of diabetes mellitus: a comprehensive review with clinicopathological insights from a dedicated high-risk diabetic foot multidisciplinary team. The British Journal of Radiology, 88(1053). https://doi.org/doi:  10.1259/bjr.20150135

Paul, S. K., Klein, K., Thorsted, B. L., Wolden, M. L., & Khunti, K. (2015). Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovascular Diabetology, 14(1). https://doi.org/10.1186/s12933-015-0260-x

Personalised blood pressure ranges in type 2 diabetes?- ClinicalKey. (n.d.-a). https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858718300020

Personalised blood pressure ranges in type 2 diabetes?- ClinicalKey. (n.d.-b). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300020

Personalised treatment targets in type 2 diabetes patients: The Dutch approach - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1751991816300626

Pickering, R. J., Rosado, C. J., Sharma, A., Buksh, S., Tate, M., & de Haan, J. B. (2018). Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clinical & Translational Immunology, 7(4). https://doi.org/10.1002/cti2.1016

Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., Graham, I., Hall, M. S., Hobbs, F. D. R., Løchen, M.-L., Löllgen, H., Marques-Vidal, P., Perk, J., Prescott, E., Redon, J., … Verschuren, W. M. M. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis, 252, 207–274. https://doi.org/10.1016/j.atherosclerosis.2016.05.037

Proceedings of the 5th International DAWN Summit 2014: Acting together to make person-centred diabetes care a reality - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822715001862

Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017a). Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. New England Journal of Medicine, 376(15), 1407–1418. https://doi.org/10.1056/NEJMoa1608664

Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017b). Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. New England Journal of Medicine, 376(15), 1407–1418. https://doi.org/10.1056/NEJMoa1608664

Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009). Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. The Lancet, 373(9677), 1765–1772. https://doi.org/10.1016/S0140-6736(09)60697-8

Richard W. Nesto. (2008). LDL cholesterol lowering in type 2 diabetes: what is the optimum approach? Clinical Diabetes, 26(1). http://go.galegroup.com/ps/i.do?id=GALE|A174972167&v=2.1&u=leicester&it=r&p=EAIM&sw=w&asid=07d8e79bb8f42665bb52cc5732948c88

Ritholz, M. D., MacNeil, T., & Weinger, K. (2017a). Difficult conversations: adults with diabetes and the discussion of microvascular complications. Diabetic Medicine. https://doi.org/10.1111/dme.13419

Ritholz, M. D., MacNeil, T., & Weinger, K. (2017b). Difficult conversations: adults with diabetes and the discussion of microvascular complications. Diabetic Medicine, 34(10), 1447–1455. https://doi.org/10.1111/dme.13419

Romero-Aroca, P., Navarro-Gil, R., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., & Soler, N. (2017a). Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2016-310063

Romero-Aroca, P., Navarro-Gil, R., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., & Soler, N. (2017b). Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2016-310063

Romero-Aroca, P., Navarro-Gil, R., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., & Soler, N. (2017c). Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2016-310063

Rosenberg, J. B., & Tsui, I. (2017). Screening for Diabetic Retinopathy. New England Journal of Medicine, 376(16), 1587–1588. https://doi.org/10.1056/NEJMe1701820

Saha, S. A., & Arora, R. R. (2010). Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials. International Journal of Cardiology, 141(2), 157–166. https://doi.org/10.1016/j.ijcard.2008.11.211

Santi, D., Granata, A. R. M., Guidi, A., Pignatti, E., Trenti, T., Roli, L., Bozic, R., Zaza, S., Pacchioni, C., Romano, S., Nofer, J. R., Rochira, V., Carani, C., & Simoni, M. (2016). Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial. European Journal of Endocrinology, 174(4), 513–522. https://doi.org/10.1530/EJE-15-1100

Schrier, R. W., Estacio, R. O., & Jeffers, B. (1996). Appropriate Blood Pressure Control in NIDDM (ABCD) Trial. Diabetologia, 39(12), 1646–1654. https://doi.org/10.1007/s001250050629

Scott, A. R. (2015). Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabetic Medicine, 32(6), 714–724. https://doi.org/10.1111/dme.12757

Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., & Khunti, K. (2016). Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials. Diabetic Medicine, 33(3), 280–289. https://doi.org/10.1111/dme.12885

Soliman, E. Z., Backlund, J.-Y. C., Bebu, I., Orchard, T. J., Zinman, B., & Lachin, J. M. (2017). Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care, 40(6), 793–799. https://doi.org/10.2337/dc16-2050

Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017a). Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40(3), 412–418. https://doi.org/10.2337/dc16-2641

Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017b). Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418. Diabetes Care. https://doi.org/10.2337/dc17-er06e

Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017c). Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418. Diabetes Care. https://doi.org/10.2337/dc17-er06e

Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017d). Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418. Diabetes Care, 40(6), 809.3-809. https://doi.org/10.2337/dc17-er06e

Sultan, A., Perriard, F., Macioce, V., Mariano-Goulart, D., Boegner, C., Daures, J.-P., & Avignon, A. (2017a). Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study. Diabetic Medicine. https://doi.org/10.1111/dme.13364

Sultan, A., Perriard, F., Macioce, V., Mariano-Goulart, D., Boegner, C., Daures, J.-P., & Avignon, A. (2017b). Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study. Diabetic Medicine. https://doi.org/10.1111/dme.13364

The changing face of diabetes complications - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716300109

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. (1993). New England Journal of Medicine, 329(14), 977–986. https://doi.org/10.1056/NEJM199309303291401

The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management - ClinicalKey. (n.d.). https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0026049515003728

The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management - NHS Health Check. (n.d.). http://www.healthcheck.nhs.uk/news/the_handbook_for_vascular_risk_assessment_risk_reduction_and_risk_management/

Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., Neal, B. C., Ninomiya, T., Patel, A. A., Paul, S. K., Travert, F., & Woodward, M. (2009a). Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia, 52(11), 2288–2298. https://doi.org/10.1007/s00125-009-1470-0

Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., Neal, B. C., Ninomiya, T., Patel, A. A., Paul, S. K., Travert, F., & Woodward, M. (2009b). Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia, 52(11), 2288–2298. https://doi.org/10.1007/s00125-009-1470-0

Type 1 diabetes in adults: diagnosis and management | Guidance and guidelines | NICE. (n.d.). https://www.nice.org.uk/guidance/ng17

Type 2 diabetes in adults: management | Guidance and guidelines | NICE. (n.d.). https://www.nice.org.uk/guidance/ng28

UK Prospective Diabetes Study Group. (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ : British Medical Journal, 317(7160). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC28659/

Umpierrez, G., & Korytkowski, M. (2016a). Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nature Reviews Endocrinology, 12(4), 222–232. https://doi.org/10.1038/nrendo.2016.15

Umpierrez, G., & Korytkowski, M. (2016b). Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nature Reviews Endocrinology, 12(4), 222–232. https://doi.org/10.1038/nrendo.2016.15

Valencia, W. M., & Florez, H. (2017). How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. https://doi.org/10.1136/bmj.i6505

Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., & Sattar, N. (2011). Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men: influence of age at onset, diabetes duration and established and novel rosk factors. Archives of Internal Medicine, 171(5). https://doi.org/10.1001/archinternmed.2011.2

Webb, D. R., Zaccardi, F., Davies, M. J., Griffin, S. J., Wareham, N. J., Simmons, R. K., Rutten, G. E., Sandbaek, A., Lauritzen, T., Borch-Johnsen, K., & Khunti, K. (2016). Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.2877

Weber, M. A., Bakris, G. L., Jamerson, K., Weir, M., Kjeldsen, S. E., Devereux, R. B., Velazquez, E. J., Dahlöf, B., Kelly, R. Y., Hua, T. A., Hester, A., & Pitt, B. (2010). Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. Journal of the American College of Cardiology, 56(1), 77–85. https://doi.org/10.1016/j.jacc.2010.02.046

Whelton, P. K. (2005). Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia. Archives of Internal Medicine, 165(12). https://doi.org/10.1001/archinte.165.12.1401

White, J., Swerdlow, D. I., Preiss, D., Fairhurst-Hunter, Z., Keating, B. J., Asselbergs, F. W., Sattar, N., Humphries, S. E., Hingorani, A. D., & Holmes, M. V. (2016). Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. JAMA Cardiology, 1(6). https://doi.org/10.1001/jamacardio.2016.1884

Wong, M. G., Perkovic, V., Chalmers, J., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., Heller, S., MacMahon, S., Mancia, G., Marre, M., Matthews, D., Neal, B., Poulter, N., Rodgers, A., Williams, B., & Zoungas, S. (2016a). Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care, 39(5), 694–700. https://doi.org/10.2337/dc15-2322

Wong, M. G., Perkovic, V., Chalmers, J., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., Heller, S., MacMahon, S., Mancia, G., Marre, M., Matthews, D., Neal, B., Poulter, N., Rodgers, A., Williams, B., & Zoungas, S. (2016b). Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care, 39(5), 694–700. https://doi.org/10.2337/dc15-2322

Yavuz, M., Ersen, A., Hartos, J., Schwarz, B., Garrett, A. G., Lavery, L. A., Wukich, D. K., & Adams, L. S. (2017). Plantar Shear Stress in Individuals With a History of Diabetic Foot Ulcer: An Emerging Predictive Marker for Foot Ulceration. Diabetes Care, 40(2), e14–e15. https://doi.org/10.2337/dc16-2204

Yudkin, J. S., Richter, B., & Gale, E. A. (2011). Intensified glucose control in type 2 diabetes—whose agenda? The Lancet, 377(9773), 1220–1222. https://doi.org/10.1016/S0140-6736(10)61112-9

Zaccardi, F., Webb, D. R., Davies, M. J., Dhalwani, N. N., Gray, L. J., Chatterjee, S., Housley, G., Shaw, D., Hatton, J. W., & Khunti, K. (2017). Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation. Diabetologia. https://doi.org/10.1007/s00125-017-4235-1

Zaccardi, F., Webb, D. R., Davies, M. J., Dhalwani, N. N., Housley, G., Shaw, D., Hatton, J. W., & Khunti, K. (2017). Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12941

Zhang, C.-Y., Sun, A.-J., Zhang, S.-N., Wu, C., Fu, M.-Q., Xia, G., Wang, K.-Q., Zou, Y.-Z., & Ge, J.-B. (2010). Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: A meta-analysis. Annals of Medicine, 42(4), 305–315. https://doi.org/10.3109/07853891003796752

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Inzucchi, S. E. (2015). Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. New England Journal of Medicine, 373(22), 2117–2128. https://doi.org/10.1056/NEJMoa1504720

Zoungas, S., Arima, H., Gerstein, H. C., Holman, R. R., Woodward, M., Reaven, P., Hayward, R. A., Craven, T., Coleman, R. L., & Chalmers, J. (2017). Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. The Lancet Diabetes & Endocrinology, 5(6), 431–437. https://doi.org/10.1016/S2213-8587(17)30104-3